Press Release (ePRNews.com) - Maharashtra, India - Mar 01, 2016 - The report “Anti-snoring Devices and Snoring Surgery Market by Device Type (MADs, TRD, Nasal Dilator, Chin Strap, Position Control, Pillows, TSD, EPAP), Surgical Procedure (UP3, LAUP, RFA, Sclerotherapy, Pillar, Others (Septoplasty, ESS)) – Global Trends & Forecast to 2020” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).
The anti-snoring treatments market is expected to reach USD 1,232.6 Million by 2020 from USD 744.7 Million in 2015, growing at a CAGR of 10.6% from 2015 to 2020.
Anti-snoring Devices and Snoring Surgery Market categories the Global Market by Device Type (Nasal Dilator, MADs, TRD, Position Control, Pillows, TSD, EPAP, Chin Strap), Surgical Procedure (LAUP, UP3, Pillar, RFA, Sclerotherapy, Others (Septoplasty, ESS)) & by Geography
The report segments the anti-snoring treatments market on the basis of device type, surgical procedure, and region. The oral appliances segment is expected to account for the largest share of the anti-snoring devices market in 2015, followed by the nasal devices segment. The oral appliances segment is also poised to grow at the highest CAGR during the forecast period, owing to growing awareness among dentists and patients regarding the use of oral appliances, recommendation as a first line of anti-snoring treatment from health organizations in several regions, and launch of new and advanced products.
Geographically, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into the U.S. and Canada; while, Europe is further subsegmented into Germany, the U.K., France, and Rest of Europe (RoE). North America is estimated to account for the largest share of the anti-snoring treatments market in 2015 and is also poised to be the fastest-growing region during the forecast period.
In the anti-snoring treatments market, the devices market is expected to grow at a higher rate as compared to surgical procedures. The anti-snoring devices market is highly fragmented; players in this market offer several products across different subsegments of this market. The anti-snoring devices market is dominated by the oral appliances segment. Some of the key players in the oral appliances market include Sleeping Well, LLC (U.S.), Apnea Sciences Corporation (U.S.), Tomed Dr. Toussaint GmbH (Germany), Sleep Well Enjoy Life, Ltd. (U.K.), and MEDiTAS Ltd. (U.K.). Nasal devices is the second-largest market, which is led by GlaxoSmithKline, plc (U.K.).